Havn Life Sciences Stock Probability of Future Pink Sheet Price Finishing Under 0.0052
| HAVLF Stock | USD 0.01 0.00 0.00% |
HAVN |
HAVN Life Target Price Odds to finish below 0.0052
The tendency of HAVN Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 0.01 | 90 days | 0.01 | about 98.0 |
Based on a normal probability distribution, the odds of HAVN Life to move below current price in 90 days from now is about 98.0 (This HAVN Life Sciences probability density function shows the probability of HAVN Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon HAVN Life Sciences has a beta of -4.04. This usually indicates as returns on its benchmark rise, returns on holding HAVN Life Sciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, HAVN Life is expected to outperform its benchmark. In addition to that HAVN Life Sciences has an alpha of 77.7784, implying that it can generate a 77.78 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). HAVN Life Price Density |
| Price |
Predictive Modules for HAVN Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as HAVN Life Sciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.HAVN Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. HAVN Life is not an exception. The market had few large corrections towards the HAVN Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold HAVN Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of HAVN Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 77.78 | |
β | Beta against Dow Jones | -4.04 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.12 |
HAVN Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of HAVN Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for HAVN Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| HAVN Life Sciences is way too risky over 90 days horizon | |
| HAVN Life Sciences has some characteristics of a very speculative penny stock | |
| HAVN Life Sciences appears to be risky and price may revert if volatility continues | |
| HAVN Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| HAVN Life Sciences has accumulated 561.84 K in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. HAVN Life Sciences has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist HAVN Life until it has trouble settling it off, either with new capital or with free cash flow. So, HAVN Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HAVN Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HAVN to invest in growth at high rates of return. When we think about HAVN Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 276.47 K. Net Loss for the year was (22.44 M) with profit before overhead, payroll, taxes, and interest of 89.69 K. | |
| HAVN Life Sciences has accumulated about 112.42 K in cash with (7.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
HAVN Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of HAVN Pink Sheet often depends not only on the future outlook of the current and potential HAVN Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. HAVN Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.1 M | |
| Shares Float | 7.9 M |
HAVN Life Technical Analysis
HAVN Life's future price can be derived by breaking down and analyzing its technical indicators over time. HAVN Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of HAVN Life Sciences. In general, you should focus on analyzing HAVN Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
HAVN Life Predictive Forecast Models
HAVN Life's time-series forecasting models is one of many HAVN Life's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary HAVN Life's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about HAVN Life Sciences
Checking the ongoing alerts about HAVN Life for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for HAVN Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| HAVN Life Sciences is way too risky over 90 days horizon | |
| HAVN Life Sciences has some characteristics of a very speculative penny stock | |
| HAVN Life Sciences appears to be risky and price may revert if volatility continues | |
| HAVN Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| HAVN Life Sciences has accumulated 561.84 K in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. HAVN Life Sciences has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist HAVN Life until it has trouble settling it off, either with new capital or with free cash flow. So, HAVN Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HAVN Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HAVN to invest in growth at high rates of return. When we think about HAVN Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 276.47 K. Net Loss for the year was (22.44 M) with profit before overhead, payroll, taxes, and interest of 89.69 K. | |
| HAVN Life Sciences has accumulated about 112.42 K in cash with (7.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Other Information on Investing in HAVN Pink Sheet
HAVN Life financial ratios help investors to determine whether HAVN Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HAVN with respect to the benefits of owning HAVN Life security.